PROVECTUS BIOPHARMACEUTICALS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2022-03-31 was $150.00K.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2015-12-31 was $0.00.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2015-09-30 was $0.00.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2002-04-23 was $25.00K.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2022 was $150.00K.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2017 was $17.30K.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2015 was $12.10M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2022-12-31 | $150.00K 10-K · filed 2024-03-28 | |
| 2022-03-31 | $150.00K 10-Q · filed 2023-11-14 | |
| 2017-12-31 | $17.30K 10-K · filed 2019-03-07 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $12.10M 10-K · filed 2017-03-31 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | |
| 2002-04-23 | $25.00K 10-Q · filed 2014-08-07 |